Be the first to like.

Share

Seeking to recover from sensational marketing scandals, GlaxoSmithKline did something unexpected five years ago — the company promised it would no longer pay doctors to promote its medicines, which had been a long-standing industry practice.

The move came not long after Glaxo paid $3 billion in fines in the U.S. for illegal marketing and kickbacks, among other things, and also followed reports the company showered doctors and government officials in China with bribes. With its announcement, Glaxo won praise for setting a new tone and raised hopes other drug makers would follow suit.

They did not.

…continue reading ‘One of the World’s Largest Drug Makers is Paying Docs Again’

Be the first to like.

Share
STAT

Tags: , , , , , , , , , , , , ,

Leave a Reply